The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
The positions in the table below reflect the Labcorp Drug Development's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to ...
The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the ...
StockStory.org on MSN
A look back at drug development inputs & services stocks’ Q4 earnings: Repligen (NASDAQ:RGEN) vs the rest of the pack
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
TOLEDO, Ohio, Jan. 8, 2026 /PRNewswire/ -- NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of ...
With a market cap of $19.2 billion, Labcorp Holdings Inc. (LH) is a leading global life sciences company specializing in diagnostic testing and drug development services. The Burlington, North ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results